WILHELMUS CM GROENHUYSEN - 06 Jan 2022 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Operating Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for Wilhelmus CM Groenhuysen
Issuer symbol: NVCR
Transactions as of: 06 Jan 2022
Net transactions value: +$4,786
Form type: 4
Filing time: 12 Jan 2022, 16:30:22 UTC
Previous filing: 07 Sep 2021
Next filing: 07 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Ordinary Shares	Award	$4,786	+75	+0.05%	$63.82	149,974	06 Jan 2022	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person is voluntarily reporting the acquisition of shares of the issuer's ordinary shares pursuant to the NovoCure Limited Employee Share Purchase Plan ("ESPP"), for the ESPP purchase period of July 1, 20121 through December 31, 2021. This transaction is also exempt under Rule 16b-3(c).
F2	In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's ordinary shares on December 31, 2021.